TBPH vs AMGN: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Amgen Inc in 2026
TBPH
Theravance Biopharma Inc
$17.23
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | TBPH | AMGN | Winner |
|---|---|---|---|
| Market Cap | $864.05M | $191.53B | AMGN |
| P/E Ratio | 8.15 | 24.57 | TBPH |
| EPS (TTM) | $2.06 | $14.46 | AMGN |
| Revenue Growth | 1.4% | 0.1% | TBPH |
| Gross Margin | 65.2% | 70.8% | AMGN |
Analyze TBPH
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or AMGN a better investment?
Comparing TBPH and AMGN: Theravance Biopharma Inc has a market cap of $864.05M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and AMGN?
TBPH (Theravance Biopharma Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or AMGN?
Based on P/E ratios, TBPH trades at a lower multiple (8.1x vs 24.6x).
Which is growing faster: TBPH or AMGN?
TBPH has higher revenue growth at 1.4% vs 0.1% for AMGN.
Which company is more profitable: TBPH or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 65.2% for TBPH.
Which is the larger company: TBPH or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $864.05M for TBPH.
Should I buy TBPH or AMGN in 2026?
Both TBPH and AMGN have investment merit. TBPH trades at $17.23 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and AMGN stock?
Key differences: Market Cap ($864.05M vs $191.53B), P/E Ratio (8.1x vs 24.6x), Revenue Growth (1.4% vs 0.1%), Gross Margin (65.2% vs 70.8%).